Buffalo Wild Wings, Inc. (NASDAQ: BWLD) was raised to Neutral from Underperform at Wedbush Securities, noting that it was also still cautious on Starbucks and Chipotle into earnings.
Carrizo Oil & Gas, Inc. (NASDAQ: CRZO) was downgraded to Neutral from Overweight and the target price was cut to $21 from $30 (versus $17.15 close) at JPMorgan.
Cision Ltd. (NYSE: CISN) was started with an Outperform rating and was given a $14 price target (versus $10.95 close) at Credit Suisse. The firm noted that this is a unique asset with a vast market opportunity.
Enova International, Inc. (NYSE: ENVA) was reiterated as Buy and the fair value estimate was raised to $18 from $16 (versus $16.45 close) at Janney.
EP Energy Corp. (NYSE: EPE) was downgraded to Sector Perform from Outperform and the price target was slashed to $4.50 from $7 (versus $3.71 close) at RBC Capital Markets. EP Energy has a 52-week range of $3.29 to $7.49.
Energen Corp. (NYSE: EGN) was downgraded to Neutral from Overweight and the price target was lowered to $53 from $60 (versus $51.39 close) at JPMorgan.
Freshpet, Inc. (NASDAQ: FRPT) was started as In-Line with a $16.50 target price (versus a $17.55 close) at Imperial Capital.
Gulfport Energy Corp. (NASDAQ: GPOR) was downgraded to Neutral from Overweight and the price target was cut to $17 from $22 (versus $13.75 close) at JPMorgan.
Guaranty Bancorp (NASDAQ: GBNK) was downgraded to Market Perform from Outperform at Keefe Bruyette & Woods.
IMAX Corporation (NYSE: IMAX) was reiterated as Outperform with a $35 target price at Wedbush Securities. After a $20.65 close, the firm noted that a tough summer box office lineup of movies has offered new investors an attractive entry point.
Johnson & Johnson (NYSE: JNJ) was reinstated as Outperform with a $148 target price at Credit Suisse. The firm still sees pharma growth drivers poised to deliver further upside for J&J investors.
Royal Caribbean Cruises Ltd. (NYSE: RCL) was raised to Overweight from Neutral and the price target was lifted to $130 from $111 at JPMorgan.
Toll Brothers Inc. (NYSE: TOL) was reiterated as Buy and the price target was raised to $45 from $43 at Argus.
UnitedHealth Group Inc. (NYSE: UNH) was reiterated as Buy and that target price was raised to $215 at Argus, noting strong earnings results.
U.S. Bancorp (NYSE: USB) was raised to Buy from Hold with a $57 price target at Argus.
Wednesday’s top analyst upgrades and downgrades were in Cameco, Carvana, Chipotle, Magellan Midstream, Netflix, Puma Bio, SeaWorld and many more companies.